Novel Risk Markers and Clinical Practice

New England Journal of Medicine

Volumn 349, Issue 17, 2003, Pages 1587-1589

  Manolio, Teri ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; GLUTATHIONE PEROXIDASE; METALLOPROTEINASE; MYELOPEROXIDASE;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CORONARY RISK; DISEASE MARKER; HUMAN; INFLAMMATION; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; GLUTATHIONE PEROXIDASE; HUMANS; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0142120730     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMp038136     Document Type: Review

References (6)

1. Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 2003;108:250-2.
2. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
3. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
4. Sakkinen PA, Macy EM, Callas PW, et al. Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. Am J Epidemiol 1999;149:261-7.
5. Zhang R, Brennan ML, Fu X, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001;286:2136-42.
6. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-5.